Home › Funds › Two Sigma Investments › NPCE
Two Sigma Investments position in NPCE
NEUROPACE INC · Health Care
Latest position (Q2 2026)30.19K sh
Reported value held$479.75K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 33.09K | $250.19K | New |
| Q4 2024 | 26.15K | $292.57K | New |
| Q1 2025 | 32.43K | $398.59K | Add |
| Q1 2025 | 32.43K | $398.59K | Add |
| Q2 2025 | 88.64K | $987.43K | Add |
| Q2 2025 | 88.64K | $987.43K | Add |
| Q3 2025 | 19.29K | $198.91K | Reduce |
| Q4 2025 | 68.09K | $1.05M | Add |
| Q1 2026 | 74.09K | $974.31K | Add |
| Q2 2026 | 30.19K | $479.75K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NPCE
- Morgan Stanley 2.65M sh · $42.18M · Q2 2026
- BlackRock Inc 2.48M sh · $39.37M · Q2 2026
- Vanguard Group 1.48M sh · $22.89M · Q4 2025
- Deutsche Bank AG 938.92K sh · $14.92M · Q2 2026
- Geode Capital Management 666.30K sh · $10.59M · Q2 2026
- Fidelity Management & Research (FMR) 554.77K sh · $8.82M · Q2 2026
- Northern Trust Corp 260.02K sh · $4.13M · Q2 2026
- JPMorgan Chase & Co 173.31K sh · $2.86M · Q2 2026
- D. E. Shaw & Co 161.08K sh · $2.56M · Q2 2026
- Goldman Sachs Group 149.57K sh · $2.38M · Q2 2026
- Citadel Advisors 128.80K sh · $2.05M · Q2 2026
- Lazard Asset Management 127.73K sh · $2.03M · Q2 2026